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Bladder cancer is one of the most common malignancies in developed countries while
transitional cell carcinomas (Tee) are the origin of more than 90% of diagnosed
bladder cancers. Patients diagnosed with bladder cancer basically belong to two
clinically distinct groups, namely non-muscle invasive (which are papillary pattern) and
muscle invasive (which are solid). These carcinomas pose the greatest clinical problems
due to the high recurrence of non-muscle invasive tumors even after transurethral
resection of the tumors. At present, there are no clinically useful markers available for
identifying bladder cancer patients with a high risk of disease recurrence or
progressIon.
Multiple molecular events take place when normal epithelial cells are transformed into
tumor tissues. These can now be monitored simultaneously, by using oligonucleotide
rnicroarrays and the expression patterns of three different grades of Tee namely Tee
WHO Grade I, Tee WHO Grade II and Tee WHO Grade III (according to WHO
classification) can be established. In this study, individual cell suspensions were
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prepared from bladder tumor biopsies. Pools of cells were also prepared from non-
cancerous tissues. Total RNA was isolated and reverse transcribed into eDNA. In vitro
transcription into cRNA was carried out with the incorporation of Cy3 and Cy5 dyes.
Labeled cRNA probes were co-hybridized to the microarray slide containing 1,853
cancer related genes. Following hybridization procedure, scanning of the array slides
was carried out to identify the gene expression levels in each of the sample
investigated.
To determine the co-expression patterns displayed between different stages of the
bladder cancer, hierarchical clustering analysis that group tumors according to
similarity in their expression profile was used. Hierarchical clustering demonstrated an
unambiguous separation of TCC WHO Grade I from Grades II and III of these
urothelial tumors. In addition, based on the gene function, nine clusters of genes were
identified. These genes are associated with cell adhesion molecules, protein synthesis,
oncogenes, apoptosis markers, growth factors, immunology, cell cycle regulators,
transcription factors and angiogenesis. Fold-change analysis of gene expression
revealed 106, 49 and 51 genes that are over-expressed and 13, 186 and 132 that are
suppressed in TCC Grades I, II and III, respectively. A gene is considered differentially
expressed if its relative expression is two-fold or greater.
Because of the inherent limitations in the reliability of microarray, genes identified as
differentially expressed were validated with a PCR-based method. Real-Time peR was
able to confirmed 75% of the microarray data. These results were in concordance to
that previously reported. This study indicates that gene expression patterns can be
identified in bladder cancer by combining oligonucleotide arrays and Real-Time PCR
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analysis. These data combined with other data from similar research, could provide
insights into the extent of expression differences underlying malignancy of the bladder
cancer and reveal genes that may prove useful as diagnostic or prognostic markers.
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Kanser pundi kencing merupakan kanser yang paling kerap berlaku di negara
membangun. Kebanyakan neoplasma adalah dari jenis 'transitional cell carcinoma'
(TCC). Secara klinikal, TCC terbahagi kepada dua kumpulan iaitu yang dipanggil
sebagai 'non-muscle invasive' dan 'muscle invasive'. Karsinoma tersebut memberikan
masalah klinikal yang tinggi kerana biasanya pesakit dengan kanser 'non-muscle
invasive' mengalami masalah serangan ulangan yang kerap walaupun setelah dilakukan
prosedur 'transurethral resection'. Buat masa ini, masih tiada penanda klinikal yang
berpotensi untuk mengenalpasti pesakit kanser pundi kencing terutamanya yang
mempunyai risiko serangan ulangan atau berpotensi untuk berkembang keperingkat
yang lebih teruk.
Pelbagai perubahan molekul berlaku apabila sel epithelial normal berubah kepada sel
kanser yang kemudiannya berportensi menjadi invasif Keadaan ini boleh diperhatikan
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seeara serentak dengan adanya kaedah terbaru yang dikenali sebagai teknologi DNA
mikroatur di mana eorak pengekspresan gen-gen bagi tiga gred TCC yang dinamakan
sebagai TCC WHO Gred I, TCC WHO Gred II dan TCC WHO Gred III (berdasarkan
kepada klasifikasi WHO) dapat dikenalpasti. Dalam kajian in, suspensi sel daripada
biopsi kanser pundi kencing disediakan. Suspensi dari sel bukan kanser turut
disediakan. RNA diekstrakan dan dilakukan transkripsi berbalik untuk menghasilkan
eDNA. Transkripsi in vitro kemudiannya dilakukan bagi mendapatkan cRNA yang
seeara serentak di labelkan dengan pewarna Cy3 dan Cy5. cRNA berlabel di
hibridisasikan bersama ke atas slid mikroatur yang mengandungi 1,853 gen berkaitan
dengan kanser. Pengimbasan slaid dilakukan bagi mengenalpasti aras hibridisasi yang
mencerminkan aras ekspresi gen dalam setiap sampel kajian.
Untuk mengenalpasti corak ko-ekspresi yang dipamirkan antara gred kanser pundi
kencing yang berlainan, anal isis kelompok hiraki yang menggumpulkan kanser
berdasarkan persamaan profil ekspresi telah digunakan. Kelompok hiraki telah
menunjukkan pengasingan yang jelas antara TCC WHO Gred I dengan TCC WHO
Gred II dan TCC WHO Gred III. Berdasarkan kepada fungsi gen, sebanyak sembi Ian
kelompok gen telah dikenalpasti. Mereka adalah gen yang berkaitan dengan sel
molekul pelekap, sintesis protin, onkogen, penanda apoptosis, faktor transkripsi,
pengawalatur kitaran sel, faktor pertumbuhan, imunologi dan angiogenesis. Analisis
perubahan pengekspresan gen telah mendapati 106, 49 dan 51 gen menunjukan corak
pengekspresan melebih i dua kali ganda manakala 13, 186 and 132 gen yang
menunjukan corak perencatan dalam TCC Gred I, II and III, masing-masing. Gen
dianggap menunjukkan pengekspresan berbeza apabila ekspresi relatifnya adalah dua
kali lebih dari sampel kawalan.
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Oleh kerana terdapat faktor penghad dalam reliabiliti teknik mikroatur, gen yang
dikenalpasti menunjukkan pengekspresan yang berbeza telah disahkan semula
menggunakan kaedah Real-Time PCR. Kaedah ini telah mengesahkan 75% daripada
data mikroatur. Keputusan ini adalah sama dengan apa yang telah dilaporkan sebelum
ini. Kajian ini telah mencadangkan corak pengekspresan gen boleh dikenalpasti dengan
mengabungkan kaedah mikroatur dan kaedah Real-Time PCR. Pergabungan data yang
dihasilkan dalam kajian ini serta hasil penemuan penyelidik lain dalam kajian yang
berkaitan dapat memberikan informasi mengenai perbezaan ekspresi gen yang berlaku
dalam setiap proses perkembangan kanser pundi kencing dan seterusnya mendedahkan
gen yang berpotensi sebagai penanda diagnostik dan prognostik.
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